2004年

  1. Xu Y, Arai H, Zhuge X, Sano H, Murayama T, Yoshimoto M, Heike T, Nakahata T, Nishikawa SI, Kita T, Yokode M: Role of Bone Marrow-Derived Progenitor Cells in Cuff-Induced Vascular Injury in Mice. Arterioscler Thromb Vasc Biol. 24:477-482.
  2. Tsuji Y, Kanamori H, Murakami G, Yokode M, Mezaki T, Doh-ura K, Taniguchi K, Matsubayashi K, Fukuyama H, Kita T, Tanaka M: Heidenhain variant of Creutzfeldt-Jakob disease: diffusion-weighted MRI and PET characteristics. J Neuroimaging. 14(1): 63-6.
  3. Abe H, Matsubara T, Iehara N, Nagai K, Takahashi T, Arai H, Kita T, Doi T: Type IV Collagen Is Transcriptionally Regulated by Smad 1 under Advanced Glycation End Product (AGE) Stimulation. J. Biol. Chem. 279(14): 14201-14206.
  4. Ohashi S, Abe H, Takahashi T, Yamamoto Y, Takeuchi M, Arai H, Nagata K, Kita T, Okamoto H, Yamamoto H, Doi T: Advanced Glycation End Products Increase Collagen-specific Chaperone Protein in Mouse Diabetic Nephropathy. J. Biol. Chem. 279(19): 19816-19823.
  5. Togi K, Kawamoto T, Yamauchi R, Yoshida Y, Kita T and Tanaka M: Role of HAND1/eHAND in the Dorso-Ventral Patterning and Interventricular Septum Formation in the Embryonic Heart. Mol. Cell. Biol. 24(11): 4627-4635.
  6. Kita T: Coronary heart disease risk in Japan ? an East/West divide? European Heart Journal Supplements (2004) 6 (Supplement A), A1-A4
  7. Maruyama T, Yamashita S, Matsuzawa Y, Bujo H, Takahashi K, Saito Y, Ishibashi S, Ohashi K, Shionoiri F, Gotoda T, Yamada N, and Kita T, on behalf of the Research Committee on Primary Hyperlipidemia of the Ministry of Health and Welfare of Japan. Mutations in Japanese Subjects with Primary Hyperlipidemia?Results from the Research Committee of the Ministry of Health and Welfare of Japan since 1996?Journal of Atherosclerosisi and Thrombosis.11(3): 131-145.
  8. Bujo H, Takahashi K, Saito Y, Maruyama T, Yamashita S, Matsuzawa Y, Ishibashi S, Shionoiri F, Yamada N, and Kita T on behalf of the Research Committee on Primary Hyperlipidemia of the Ministry of Health, Labour and Welfare of Japan. Clinical Features of Familial Hypercholesterolemia in Japan in a Database from 1996-1998 by the Research Committee of the Ministry of Health, Labour and Welfare of Japan. Journal of Atherosclerosisi and Thrombosis.11(3): 146-151.
  9. Fukumoto N, Shimaoka T, Fujimura H, Sakoda S, Tanaka M, Kita T, Yonehara S:Critical Roles of CXC Chemokine Ligand 16/Scavenger Recepter that Binds Phosphatidylserine and Oxidized Lipoprotein in the Pathogenesis of Both Acute and Adoptive Transfer Experimental Autoimmune Encephalomyelitis. J Immunol.173: 1620-1627.
  10. Oida E, Nogaki F, Kobayashi I, Kamata T, Ono T, Miyawaki S, Serikawa T, Yoshida H, Kita T, Muso E. Quantitative trait loci (QTL) analysis reveals a close linkage between the hinge region and Trimeric IgA dominancy in a high IgA strain (HIGA) of ddY mice. Eur. J. Immunology. 34: 2200-2208.
  11. Wada T, Ishine M, Sakagami T, Okumiya K, Fujisawa M, Murakami S, Otsuka K, Yano S, Kita T, Matsubayashi K. Depression in Japanese community-dwelling elderly?prevalence and association with ADL and QOL. Arch.Gerontol.Geriatr.39: 15-23.
  12. Kobayashi T, Tahara Y, Matsumoto M, Iguchi M, Sano H, Maruyama T, Arai H, Oida H, Yurugi-Kobayashi T, Yamashita J K., Katagiri H, Majima M, Yokode M, Kita T, Narumiya S: Roles of thromboxane A?and prostacyclin in the development of atherosclerosis in apoE-deficient mice. JCI. 114:784-794.
  13. Ono T, Liu N, Makino T, Nogaki F, Nomura K, Muso E, Shimizu F, Honda G, Kita T.Role of mesangial Factor V expression in the crescent formation in rat experimental mesangioproliferative glomerulonephritis. J Pathol. 204:229-238.
  14. Liu N, Makino T, Nogaki F, Kusano H, Suyama K, Muso E, Honda G, Kita T, Ono T. Coagulation in the mesangial area promotes ECM accumulation through factor V expression in MsPGN in rats. Am J Physiol Renal Physiol. 287: F612-F620.
  15. Liu N, Makino T, Honda G, Muso E, Kita T, Ono T. Suppressive effects of Sairei-to on mesangial proliferation in a rat model of glomerulonephritis. Clin Exp Nephrol. 8:216-222.
  16. Ohashi H, Takagi H, Koyama S, Oh H, Watanabe D, David A.Antonetti, Matsubara T, Nagai K, Arai H, Kita T, Honda Y: Alterations in expression of angiopoietins and the Tie-2 receptor in the retina of streptozotocin induced diabetic rats. Molecular Vision. 10: 608-617.
  17. Tanaka M, Namiki C, Dinh H,D,T, Yoshida H, Kawasaki K, Hashikawa K, Fukuyama H, Kita T: Prediction of psychiatric response to donepezil in patients with mild to moderate Alzheimer's disease. Journal of the Neurological Sciences.
  18. Zhuge X, Kataoka H, Tanaka M, Murayama T, Kawamoto T, Sano H, Togi K, Yamauchi R, Xu Y, Nishikawa S-I, Kita T, Ueda Y, Yokode M: Expression of Smuc, a Novel Snail-related Zinc Finger Transcription Factor, During Pre and Postnatal Mouse Development (in revision)
  19. Funabiki Y, Ishii K, Iehara N, Hakamata Y, Doi T, Murakami T, Yokode M, Wakatsuki Y, Kume N, Kita, T: Tuberculosis Associated with a High Serum CA19-9 Level. (in preparation)
  20. Kita T, Kume N, Ochi H, Nishi E, Nagano Y and Yokode M: Lysophosphatidylcholine induced gene expression of endothelial platelet-derived growth factor-b-chain and intercellular adhesion molecule-1. Medical Science Symposia Series, [in press]
  21. Clinical Features of Familial Hypercholesterolemia in Japan at the database during 1996-1998 of the Research Committee of the Ministry of Health and Welfare of Japan. JAT. [in press]
  22. Ishine M, Wada T, Akamatsu K, Matheus R,C, Sakagami T, Kita T, Okumiya K, Matsubayashi K: No Positive Correlation between Anemia and Disability in the Elderly in Japan. J. Am. Geriatr. Soc, 2004 [in press]
  23. Tanaka M, Kita T: Paroxetine and improvement of visual hallucinations in patients with dementia with Lewy bodies. J. Am. Geriatr. Soc, 2004 [in press]
  24. Tanaka M, Kita T: Paroxetine and improvement of visual hallucinations in patients with dementia with Lewy bodies. J. Am. Geriatr. Soc, 2004 [in press]
  25. Kume N, Hayashida K, Minami M, Inui-Hayashida A, Mukai E, Toyohara M, Kita T: Peroxisome proliferator-activated receptor ligands activate transcription of lectin-like oxidized low density lipoprotein receptor-1(LOX-1) gene through GC box motif .BBRC, 2004-2454.
  26. Nagai K, Matsubara T, Mima A, Sumi E, Kanamori H, Iehara N, Fukatsu A, Yanagita M, Nakano T, Ishimoto Y, Kita T, Doi T, and Arai H. Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy. Kidney International [in press]
  27. Tanaka M, Arai H, Liu N, Nogaki F, Nomura K, Kasuno K, Oida E, Kita T, and Ono T: Role of coagulation factor Xa and protease-activated receptor 2 in human mesangial cell proliferation. Kidney International, [in press]
  28. Takahashi T, Abe H, Arai, H, Matsubara T, Nagai K, Matsuura M, Iehara N, Yokode M, Nishikawa S, Kita T, and Doi T: Activation of STAT3/Smad1 is a key signaling pathway for progression to glomerulosclerosis in experimental glomerulonephritis. J Biol Chem 280:7100-7106, 2005.
  29. Arai H, Yamamoto A, Matsuzawa Y, Saito Y, Yamada N, Oikawa S, Mabuchi H, Teramoto T, Sasaki J, Nakaya N, Itakura H, Ishikawa Y, Ouchi Y, Horibe H, and Kita T: Serum Lipid Survey and its Recent Trend in the General Japanese Population in 2000, J Arteriosclerosis Thrombosis, [in press]
  30. Matsumori A: Clinical Implications of the ARCH-J and CHARM Trials. J Hong Kong Coll Cardiol 12(Suppl 1): A35-A38.
  31. Matsumori A: Heart Failure: The Asian Perspective - Japan. J Hong Kong Coll Cardiol 12(Suppl 1): A51-A53.
  32. Matsumori A, Nunokawa Y, Yamaki A, Yamamoto K, Hwang MW, Miyamoto T, Hara M, Nishio R, Kitaura-Inenaga K, Ono K: Suppression of cytokines and nitric oxide production against lethal endotoxemia and viral myocarditis by a new NF-kB inhibitor. Eur J Heart Fail 6: 137-144.
  33. Matsumori A: Anti-inflammatory therapy for heart failure. Curr Opin Pharmacol 4: 171-176.
  34. Katoh H, Shimada T, Inoue S, Takahashi N, Shimizu H, Ohta Y, Nakamura K, Murakami Y, Ishibashi Y, Matsumori A: Reduced high serum hepatocyte growth factor levels after successful cardioversion in patients with atrial fibrillation. Clin Exp Pharmacol Physiol 31: 145-151.
  35. Hata N, Matsumori A, Yokoyama S, Ohba T, Shinada T, Yoshida H, Tokuyama K, Imaizumi T, Mizuno K: Hepatocyte growth factor and cardiovascular thrombosis in patients admitted to the intensive care unit. Circ J 68: 645-649.
  36. Masuda D, Fujita M, Nohara R, Matsumori A, Sasayama S: Improvement of oxygen metabolism in ischemic myocardium as a result of enhanced external counterpulsation with heparin pretreatment for patients with stable angina. Heart Vessels 19: 59-62.
  37. Matsumori A: Roles of Hepatocyte growth factor and mast cells in thrombosis and angiogenesis. Cardiovasc Drugs Ther 18:321-326.
  38. Matsumori A: The role of NF-kB in the pathogenesis of heart failure and endotoxemia. Drugs of the Future 29: 733-739.
  39. Taniguchi R, Sato Y, Yamada T, Ooba M, Higuchi H, Matsumori A, Kimura T, Kita T: Combined measurements of cardiac troponin T and N-terminal pro-brain natriuretic peptide in patients with heart failure. Circ J 68: 1160-1164.
  40. Matsumori A: Role of hepatitis C virus in myocarditis and cardiomyopathies. J Geriatric Cardiol 1: 83-89.
  41. Hara M, Ono K, Wada H, Sasayama S, Matsumori A: Performed angiotensin II is present in human mast cells. Cardiovasc Drugs Ther 18: 415-420.
  42. Furukawa Y, Cole SE, Shah RV, Fukumoto Y, Libby P, Mitchell RN:Wild-type but not interferon-g-deficient T cells induce graft arterial disease in the absence of B cells. Cardiovasc Res 63: 347-356.
  43. Nishiyama K, Okino S, Andou J, Nakagawa Y, Kimura T, Nobuyoshi M.:Coronary angioplasty reduces free wall rupture and improves mortality and morbidity of acute myocardial infarction. J Invasive Cardiol. 2004 Oct; 16(10): 554-8.
  44. Nakamura T, Chin K, Hosokawa R, Takahashi K, Sumi K, Ohi M, Mishima M:Corrected QT dispersion and cardiac sympathetic function in patients with obstructive sleep apnea-hypopnea syndrome. Chest 2004; 125:2107-2114
  45. Saito N, Kimura T, Toma M, Teragaki M, Minaminimura H, Kita T,Inoue K: Successful endovascular repair of an aneurysm of the ductus diverticulum with a branched stent graft: case report and review of literature.J Vasc Surg.; 40(6): 1228-33
  46. Sato Y, Kita T, Takatsu Y, Kimura T: Biochemical markers of myocyte injury in heart failure (Review). Heart; 90:1110-1113.
  47. Yuan Z, Shioji K, Kihara Y, Takenaka H, Onozawa Y, Kishimoto C. Cardioprotective effects of carvedilol on acute autoimmune myocaridtis: anti-inflammatory effects associated with antioxidant property. Am. J. Physiol. 286:H83-H90.
  48. Kihara Y: Pathophysiological roles of myocardial endothelin-1 during transition to heart failure: Studies in the Dahl rat heart transition model. In: Mizukami Y, ed. Molecular Mechanism of Heart Disease, 2005, in press.
  49. Shimaoka T, Nakayama T, Fukumoto N, Kume N, Takahashi S, Yamaguchi J, Minami M, Hayashida K, Kita T, Ohsumi J, Yoshie O, Yonehara S: Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells. J. Leukoc. Biol. 75(2): 267-274
  50. Yamauchi R, Tanaka M, Kume N, Minami M, Kawamoto T, Togi K, Shimaoka T, Takahashi S, Yamaguchi J, Nishina T, Kitaichi M, Komeda M, Manabe T, Shin Yonehara, Kita T: Upregulation of SR-PSOX/CXCL16 and recruitment of CD8+ T cells in cardiac valves during inflammatory valvular heart disease. Arterioscler. Thromb. Vasc. Biol. 24: 282-287
  51. Kume N, Kita T: Apoptosis of vascular cells by oxidized LDL: involvement of caspases and LOX-1, and its implication in atherosclerotic plaque rupture. Circ. Res. 94: 269-270
  52. Shimaoka T, Nakayama T, Hieshima K, Kume N, Fukumoto N, Minami M, Hayashida K, Kita T, Yoshie O, Yonehara S: Chemokines generally exhibit scavenger receptor activity through their receptor-binding domain. J. Biol. Chem. 279: 26807-26810
  53. Mukai E, Kume N, Hayashida K, Minami M, Yamada Y, Seino Y, Kita T: Heparin-binding EGF-like growth factor induces expression of lectin-like oxidized LDL receptor-1 in vascular smooth muscle cells. Atherosclerosis 176: 289-296
  54. Hayashida K, Kume N, Minami M, Inui-Hayashida A, Mukai E, Toyohara M, Kita T: Peroxisome proliferator-activated receptor alpha ligands activate transcription of lectin-like oxidized low density lipoprotein receptor-1 gene through GC box motif. Biochem. Biophys. Res. Commun. 323: 1116-1123
  55. Yui Y, Sumiyoshi T, Kodama K, Hirayama A, Nonogi H, Kanmatsuse K, Origasa H, Iimura O, Ishii M, Saruta T, Arakawa K, Hosoda S, Kawai C; Comparison of nifedipine retard with angiotensin converting enzyme inhibitors in Japanese hypertensive patients with coronary artery disease: The Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) randomized trial. Hypertension Research 27: 181-191
  56. Yui Y, Sumiyoshi T, Kodama K, Hirayama A, Nonogi H, Kanmatsuse K, Origasa H, Iimura O, Ishii M, Saruta T, Arakawa K, Hosoda S, Kawai C; Nifedipine retard was as effective as angiotensin converting enzyme inhibitors in preventing cardiac events in high-risk hypertensive patients with diabetes and coronary artery disease: The Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) subgroup analysis. Hypertension Research 27: 449-456
  57. The Japanese ?-blockers and calcium antagonists myocardial infarction (JBCMI) investigators: Comparison of the effects of Beta blockers and calcium antagonists on cardiovascular events after acute myocardial infarction in Japanese. Am J Cardiol 93: 969-973.
  58. Yuan Z, Shioji K, Nimata M, Kishimoto C: Cardioprotective effects of carvedilol on acute autoimmune myocarditis. Mol Cell Biochem 259, 223-227.
  59. Nimata M, Kishimoto C, Yuan Z, Shioji K: Beneficial effects of olmesartan, a novel angiotensin II receptor type 1 antagonist, upon acute autoimmune myocarditis. Mol Cell Biochem 259:217-222.
  60. Tanito M, Nakamura H, Kwon YW, Teratani A,Masutani H, Shioji K, Kishimoto C, Ohira A, Horie R, Yodoi J : Enhanced oxidative stress and impaired thioredoxin expression in spontaneously hypertensive rats. Antioxid Redox Signal 6: 89-97.
  61. Kishimoto C, Hiraoka Y, Takada H: Effects of immunoglobulin upon murine myocarditis caused by influenza A virus. Superiority of intact type to F (ab') type. J Cardiovasc Pharmacol 43: 61-67.
  62. Miyamoto M, Kishimoto C, Nimata M, Nakamura H, Yodoi J: Thioredoxin, a redox regulating protein, is expressed in spontaneous myocarditis in inbred strains of mice. Int J Cardiol 95: 315-319.
  63. Liu W, Nakamura H, Shioji K, Tanito M, Oka S, Ahsan MK, Son A, Ishii Y, Kishimoto C, Yodoi J: Thioredoxin-1 ameliorates myosin-induced autoimmune myocarditis by suppressing chemokine expressions and leukocyte chemotoxis in mice. Circulation 110:1276-1283.
  64. Yuan Z, Liu Y, Liu Y, Zhang J, Kishimoto C, Ma A, Liu Z: Peroxisome proliferator-activated receptor-g ligands ameliorate experimental autoimmune myocarditis associated with inhibition of self-sensitive T cells. J Cardiovasc Pharmacol 43: 868-875.
  65. Yuan Z, Shioji K, Kihara Y, Takenaka H, Onozawa Y, Kishimoto C: Cardioprotective effects of carvedilol on acute myocarditis. Anti-inflammatory effects associated with antioxidant property.Am J Physiol 286: H83-H90.
  66. Takada H, Kishimoto C, Kurokawa M, Hiraoka Y: Amyocarditic coxsackievirus B3 causes myocarditis in immunocompromized mice. Exp & Clin Cardiol 8: 71-75.
  67. Shioji K, Yuan Z, Kita T, Kishimoto C: Immunoglobulin treatment suppressed adoptively transferred autoimmune myocarditis in severe combined immunodeficient mice. Am J Physiol 287: H2619-H2625.
  68. Higashi T, Yoshioka A, Shirakawa R, Tabuchi A, Nishioka H, Kita T, and Horiuchi H: Direct demonstration of involvement of the adaptor protein ShcA in the regulation of Ca2+-induced platelet aggregation. Biochem. Biophys. Res. Commun 322: 700-704
  69. Horiuchi H, Matsuzawa Y, Mabuchi H, Itakura H, Sasaki J, Yokoyama M, Ishikawa Y, Yokoyama S, Mori S, Ohrui T, Akishita M, Hayashi T, Yamane K, Egusa G, and Kita T: Strategy for treating elderly Japanese with hypercholesterolemia: From the report of the Research Group for 'Long-term prognosis of elderly Japanese with hypercholesterolemia' in the Comprehensive Research on Aging and Health. Gerit. Geront. Int. 4: 151-156
  70. Horiuchi H, Kita T, Mabuchi H, Matsuzaki M, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H, and the J-LIT Study Group: Primary cardiovascular event and serum lipid levels in ederly Japanese with hypercholesterolemia under 6-Year simvastatin treatment: A sub-analysis of the J-LIT Study. J Am. Geriatr Soc 52:1981-1987
  71. Shirakawa R, Higashi T, Tabuchi A, Yoshioka A, Nishioka H, Fukuda M, Kita T, and Horiuchi H: Munc13-4 is a GTP-Rab27 binding protein regulating dense core granule secretion in platelets. J. Biol. Chem. 279(11): 10730-10737
  72. Shimizu W, Horie M, Ohno S, Takenaka K, Yamaguchi M, Shimizu M, Washizuka T, Aizawa Y, Nakamura K, Ohe T, Aiba T, Miyamoto Y, Yoshimasa Y, Towbin JA, Priori SG, Kamakura S : Mutation site-specific differences in arrhythmic risk and sensitivity to sympathetic stimulation in the LQT1 form of congenital long QT syndrome: multicenter study in Japan. J Am Coll Cardiol. 44(1): 117-25.
  73. Kobori A, Sarai N, Shimizu W, Nakamura Y, Murakami Y, Makiyama T, Ohno S, Takenaka K, Ninomiya T, Fujiwara Y, Matsuoka S, Takano M, Noma A, Kita T, Horie M. Additional gene variants reduce effectiveness of beta-blockers in the LQT1 form of long QT syndrome. J Cardiovasc Electrophysiol. 15(2): 190-9.
  74. Yumoto Y, Horie M, Kubota T, Ninomiya T, Kobori A, Takenaka K, Takano M, Niwano S, Izumi T. Bepridil block of recombinant human cardiac IKs current shows a time-dependent unblock. J Cardiovasc Pharmacol. 43(2): 178-82.
  75. Park PW, Foster TJ, Nishi E, Duncan SJ, Klagsbrun M and Chen Y: Activation of syndecan-1 ectodomain shedding by Staphylococcus aureus α and β toxins. J. Biol. Chem. 279: 251-258
  76. Nishi E and Klagsbrun M: Heparin-Binding Epidermal Growth Factor-Like Growth Factor (HB-EGF) is a Mediator of Multiple Physiological and Pathological Pathways. Growth Factors. 22: 253-260
  77. Yanagita M: BMP antagonists: their roles in development and involvement in pathophysiology. Cytokine & Growth Factor Review (in press)
  78. Yanagita M: Gas6, warfarin and kidney diseases.C
  79. Yanagita M: The role of the vitamin K-dependent growth factor Gas6 in glomerular pathophysiology.Curr Opin Nephrol Hypertens.13(4): 465-70
  80. Yanagita M, Oka M, Watabe T, Iguchi H, Niida A, Takahashi S, Akiyama T, Miyazono K, Yanagisawa M, Sakurai T: USAG-1: a bone morphogenetic protein antagonist abundantly expressed in the kidney. Biochem Biophys Res Commun. 316(2):490-500
  81. Burchfield, JG., Lennard, AJ., Narasimhan S, Hughes WE., Wasinger VC., Corthals, GL., Okuda T, Kondoh H, Biden TJ., and Schmitz-Peiffer C: Akt mediates insulin-stimulated phosphorylation of Ndrg2 ? evidence for crosstalk with protein kinase C theta. J. Biol. Chem. 279: 18623-18632
  82. Okuda, T, Higashi Y, Kokame K, Tanaka C, Kondoh H and Miyata T: Ndrg1-deficient mice exhibit progressive demyelinating disorder of peripheral nerves. Mol. Cell. Biol. 24:3949-3956
  83. Okuda T, Sumiya T, Iwai N and Miyata T: Pyridoxine 5'-phosphate oxidase is a candidate gene responsible for hypertension in Dahl-S rats. Biochem. Biophys. Res. Commun. 313: 647-653
  84. Iwai-kanai E, Hasegawa K. Intracellular singnaling pathways for norepinephrine and endothelin-1-mediated regulation of myocardial cell apoptpsis. Mol Cell Biochem 259:163-168
  85. Kawamura T, Hasegawa K, Morimoto T, Iwakura A, Nishina T, Nomoto T, Komeda M. Down-regulation of endothelin-1 and alteration of apoptosis signaling following left ventricular volume reduction surgery in heart failure of adult rats. J Cardiovasc Pharmacol. 44(Supple 1):S366-S371
  86. Ehara N, Hasegawa K, Ono K, Kawamura T, Iwai-Kanai E, Morimoto T, Akao M, Adachi S, Kita T. Activators of PPARg antagonize protection of cardiac myocytes by endothelin-1. Biochem Biophys Res Commun. 321:345-349.
  87. Hirai M, Ono K, Morimoto T, Kawamura T, Wada H, Kita T, Hasegawa K. FOG-2 competes with GATA-4 for a transcriptional coactivator p300 and represses hypertrophic responses in cardiac myocytes. J Biol Chem. 279:37640-37650.
  88. Kawamura T, Ono K, Morimoto T, Akao M, Iwai-Kanai E, Wada H, Sowa N, Kita T, Hasegawa K. Endothelin-1-dependent Nuclear Factor Activating T Lymphcytes Signaling Associates with Transcriptional Coactivator p300 in the Activation of the B Cell Leukemia-2 Promoter in Cardiac Myocytes. Circ Res. 94:1492-1499
  89. Ono K, Iwanaga Y, Hirayama M, Kawamura T, Sowa N, Hasegawa K. Contribution of caveolin-1alpha and Akt to TNF-a-induced cell death. Am J Physiol Lung Cell Mol Physiol. 287:L201-209.
  90. Kawamura T, Hasegawa K, Morimoto T, Iwai-Kanai E, Miyamoto S, Kawase Y, Ono K, Wada H, Akao M, Kita T. Expression of p300 protects cardiac myocytes from apoptosis in vivo. Biochem Biophys Res Commun. 315:733-738
  91. Ehara N, Ono K, Morimoto T, Kawamura T, Abe M, Hasegawa K. The possible role of peroxisome proliferator-activated receptor gamma in heart failure Exp. & Clin Cardiol. 9: 169-173.
  92. Miyamoto S, Fujita M, Tambara K, Sekiguchi H, Eiho S, Hasegawa K, Tamaki S. Circadian variation of cardiac autonomic nervous activity is well preserved in patients with mild to moderate chronic heart failure: effect of patient position. Int J Cardiol . 93:247-252.
  93. Tambara K, Fujita M, Miyamoto S, Doi K, Nishimura K, Komeda M: Pericardial fluid level of heart-type cytoplasmic fatty acid-binding protein (H-FABP) is an indicator of severe myocardial ischemia. Int J Cardiol 93:281-284.
  94. Fujita M, Tambara K: Recent insights into human coronary collateral development. Heart 90(3): 246-250.
  95. Tambara K, Fujita M, Miyamoto S, Sekiguchi H, Eiho S, Komeda M: Beneficial effect of candesartan treatment on cardiac autonomic nervous activity in patients with chronic heart failure: simultaneous recording of ambulatory ECG and posture. Clinical Cardiology 27(5): 300-303.
  96. Doi K, Hasegawa K, Fujita M, Yamazato A, Yamanaka K, Watanabe M, Tambara K, Komeda M: Clinical characteristics relevant to myocardial cell apoptosis: analysis of pericardial fluid. Interactive Cardiovascular and Thoracic Surgery 3:359-362.
  97. Sakamoto S, Tambara K, Kambara N, Miyamoto S, Tsukamoto T, Fujita M: Right lateral decubitus position reduces QT dispersion in patients with chronic heart failure. J Electrocardiol 37(3): 201-206.
  98. Miwa K, Okinaga S, Fujita M: Low serum α-tocopherol concentrations in subjects with various coronary risk factors. Circ J 68(6): 542-546.

ページの先頭へ